Dose Level

Phase I study of alpha-tocopherlyoxyacetic acid in patients with advanced cancer
Brendan D Curti, Emmanuel Akporiaye, Kim Sutcliffe, Keith S Bahjat, Yoshinobu Koguchi, Julie Cramer, Walter Urba

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P148; DOI: 10.1186/2051-1426-3-S2-P148
A Phase I study of NLG919 for adult patients with recurrent advanced solid tumors
Asha Nayak, Zhonglin Hao, Ramses Sadek, Nicholas Vahanian, W Jay Ramsey, Eugene Kennedy, Mario Mautino, Charles Link, Pamela Bourbo, Robin Dobbins, Kelly Adams, Allison Diamond, Lisa Marshall, David H Munn, John Janik, Samir N Khleif

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P250; DOI: 10.1186/2051-1426-2-S3-P250
High-dose treatment with ADXS11-001, a listeria monocytogenes (Lm)-listeriolysin O (LLO) immunotherapy, in women with cervical cancer
Sharad Ghamande, David Mauro, Cheryl Price, Donna Wheatley, John Janik, Samir N Khleif

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P151; DOI: 10.1186/2051-1426-3-S2-P151

Main menu